On Monday, Shares of VMware, Inc. (NYSE:VMW), lost -2.52% to $77.13.
VMware, declared the expansion of its relationship with SAP SE. SAP and VMware plan to integrate the ACE approach to enable secure, instant deployment and login of Success Factors and Concur mobile applications on iOS and Android devices. The ACE community also declared recently 21 new members, growing more than seven-fold since its inception in March 2015.
The ACE community showcases the first standard approach to configuring and securing apps in the enterprise. By leveraging the latest APIs available from the iOS, Android and Windows operating systems, ACE promotes and educates the use of a native development framework with the purpose of minimizing the effort for developers, enterprises and end users. By standardizing the app configuration and security administration leveraged by any EMM solution, enterprises can create a more seamless app experience for their end users and improvement adoption of their mobile apps.
ACE launched at Mobile World Congress 2015 and recently, ACE has more than 40 members, counting several Apple Mobility Partners. More information on ACE can be found here.
VMware, Inc. provides virtualization infrastructure solutions in the United States and internationally. The company’s virtualization infrastructure solutions comprise a suite of products designed to deliver a software-defined data center (SDDC), run on industry-standard desktop computers and servers, and support a range of operating system and application environments, in addition to networking and storage infrastructures.
Shares of Cognex Corporation (NASDAQ:CGNX), declined -1.30% to $33.52, during its last trading session.
Cognex Corporation, will release earnings for the third quarter of 2015 on Monday, November 2, 2015, after the market closes, and will host a conference call that same day at 5:00 p.m. Eastern Time (ET). The earnings release and conference call are planned to coincide with the company’s predictable filing of its Form 10-Q for the quarter ending October 4, 2015.
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes. It develops, manufactures, and markets modular vision systems and ID products that are used to automate the manufacture and tracking of discrete items, such as cellular phones, aspirin bottles, and automobile wheels by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
At the end of Monday’s trade, Shares of Diamond Foods, Inc. (NASDAQ:DMND), lost -6.22% to $31.97.
Diamond Foods, declared that it has reached a long-term planned alliance agreement with Walt Disney World Resort and Disneyland Resort tied to its Pop Secret brand premium popcorn. Pop Secret popcorn is now the official popcorn of Walt Disney World Resort in Florida and Disneyland Resort in California.
Diamond Foods also plans to advertise on Disney-owned channels like ABC Family and the Disney Channel. Retail promotions, on-pack sweepstakes and digital content creation are all ways in which Pop Secret popcorn anticipates to work with Disney.
“We have been looking for an alliance that is in-line with our core brand values and we couldn’t be more delighted to declare this relationship with Walt Disney World Resort and Disneyland Resort,” said Burke Raine, Vice President of Marketing, Snacks, at Diamond. “Pop Secret popcorn and Disney both have deep associations with movies and encourage lasting memories shaped by fun family activities.”
Diamond Foods, Inc., a packaged food company, processes, markets, and distributes snack products and nuts. It operates in two segments, Snacks and Nuts. The Snacks segment offers microwave popcorn products and potato chips under the Kettle and Pop Secret brands.
Finally, WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX), ended its last trade with -0.53% loss, and closed at $43.02.
WuXi PharmaTech, declared that it has been awarded the 2015 Frost & Sullivan North American Open-Access R&D Technology Leadership Award. The award is part of Frost & Sullivan’s Growth, Innovation & Leadership Award series, recognizing companies that have demonstrated excellence in devising and implementing strong growth strategies.
WuXi was recognized for its outstanding achievement and strong performance in assisting its customers improve their R&D productivity while reducing cost through a model of R&D enablement. Together with over 2,000 partners worldwide, WuXi is advancing breakthroughs in science and medicine that assist people around the world lead happier and healthier lives. Frost & Sullivan views WuXi as an innovator in business relationships across the entire pharmaceutical and biotechnology value chain.
“We thank Frost & Sullivan for recognizing WuXi’s diligent efforts in building an open-access R&D enabling platform,” said Dr. Ge Li, chairman and CEO of WuXi Pharma Tech. “We also thank our customers and collaborative partners for their trust and support in our journey. WuXi is honored to play an important role in assisting to bring better medicines to patients faster.”
Wuxi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development services company in China and the United States. It operates through two segments, Laboratory Services and Manufacturing Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
